AIDS 2026, the 26th International AIDS Conference, is taking place from July 26-31 in Rio de Janeiro, Brazil (and virtually). Recordings will be made publicly available by the International AIDS Society two months after the meeting ends. Links to events and sessions related to HIV cure research are appended below. Please email or comment if…

Media coverage:  A Single Infusion Could Suppress H.I.V. for Years, Study Suggests – Apoorva Mandavilli, New York Times, May 11, 2026 Small study shows one-time cell therapy can control HIV infection – by Deena Beasley, Reuters, May 11, 2026 Small study hints that revving up immune cells might help fight HIV – Lauran Neergaard, Associated…

A delayed backgrounder on last month’s update to TAG’s listing. There were 13 changes for March 2026, including one newly registered clinical trial. Notably, the last few weeks have seen some potentially encouraging signs for the future of funding support for HIV cure research from the National Institute of Allergy and Infectious Diseases (NIAID) at…

There were 24 updates to the TAG listing for February 2026, including three newly registered clinical trials. New Additions The company BioNTech is launching a phase I trial of BNT351, a new broadly neutralizing antibody (bNAb). Based on a poster (#524) presented at the Conference on Retroviruses and Opportunistic Infections (CROI) yesterday, BNT351 is a…

There were 14 updates to the TAG listing for December 2025, and a further eight for January 2026. No new HIV cure-related studies were identified in registries during this period. Updates to Enrollment Status A clinical trial testing the Janus kinase inhibitor baricitinib in Barcelona that was added to the listing in July 2025 is…

There were 10 changes to the TAG listing in the November update. The completed studies table has also been slightly reorganized to separate the previous “antibodies” category into more specific groupings: anti-α4β7 integrin antibodies, broadly neutralizing antibodies, and intravenous immune globulin (IVIG). New Additions Only one new HIV cure-related trial was added since the previous…

For October 2025, there were 29 updates to the TAG listing. We’re very grateful to the employees at the National Center for Biotechnology Information who are continuing to maintain the trial registry clinicaltrials.gov and scientific literature database PubMed during the current US Federal government shutdown (likely without pay). New Additions Three newly registered HIV cure-related…

The early termination of the Mosaico HIV vaccine trial due to lack of efficacy was announced a little over a month ago, on January 18. Yesterday at the Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, preliminary details of the results were disclosed in a short presentation by Susan Buchbinder. As outlined at the…

At the end of August, disappointing results were released from Imbokodo, a phase IIb clinical trial evaluating the efficacy of an HIV vaccine candidate developed by the Janssen Pharmaceutical Companies of Johnson & Johnson. Among cisgender women recruited in five African countries, the vaccine regimen didn’t offer significant protection against acquisition of HIV infection. The…